INIS
cancer
100%
breasts
50%
mitochondria
39%
migration
35%
genes
33%
proteins
32%
regulations
31%
macrophages
30%
metastases
30%
fibroblasts
30%
phenotype
28%
stem cells
28%
therapy
26%
tumors
23%
oxidation
22%
synthesis
22%
patients
22%
apoptosis
21%
messenger-rna
20%
carcinomas
18%
receptors
17%
histones
17%
balances
17%
control
17%
skin
17%
populations
17%
liver
15%
amino acids
15%
peptides
15%
chromatin
15%
colon
15%
cell proliferation
15%
titanium oxides
15%
transcription factors
15%
catalase
15%
maturation
15%
protons
15%
animal cells
15%
hypoxia
15%
irradiation
15%
organoids
15%
endoplasmic reticulum
15%
rna
15%
specificity
15%
porous materials
15%
budgets
15%
hybrids
15%
alginates
15%
humans
13%
aging
12%
Keyphrases
Patient-derived
15%
Budget-friendly
15%
Colonoids
15%
Transient Stress
15%
Response Activation
15%
Histone Deacetylase 2 (HDAC2)
15%
MPV17
15%
Squamous Carcinoma Cells
15%
Cutaneous Squamous Cell Carcinoma (cSCC)
15%
Staurosporine
15%
M1 Macrophages
15%
B-cell CLL/lymphoma 2
15%
Cathepsin B
15%
Indacaterol
15%
Collective Cell Migration
15%
Endoplasmic Reticulum Stress Pathway
15%
Transcription Factor 7-like 2 (TCF7L2)
15%
Amino Acid Balance
15%
Stem Cell Commitment
15%
Peroxisome Proliferator-activated Receptor-γ coactivator-1α (PGC-1α)
15%
Off-target Effects
15%
Hybrid Microcapsules
15%
Directional Cell Migration
15%
ITGB3
13%
HIV-1 LTR
11%
Hepatospecific
10%
Alginate Microcapsules
10%
Patient-derived Organoids
7%
HDAC7
7%
E1E2
7%
PARP Inhibitor (PARPi)
7%
Activating Transcription Factor 3 (ATF3)
7%
Large B-cell Lymphoma
7%
SRSF6
7%
Integrin α5
7%
Glycine Transporter
7%
Proliferator-activated Receptor-γ
6%
Non-lethal
6%
Translational Efficiency
5%
Translational Repression
5%
Proteome Remodeling
5%
Polysome Profiling
5%
Exit from Pluripotency
5%
Global Reduction
5%
Metabolic Maturation
5%
Cationic Polyamine
5%
Model Cell
5%
Additive Products
5%
Hormone Deficiency
5%
Microcapsules
5%
